The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Items 301–400 of 785
Stoffel, E. M., McKernin, S. E., & Khorana, A. A. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00629 · Cited by 22
Kumar, S., Saumoy, M., Oh, A., Schneider, Y., Brand, R. E., Chak, A., Ginsberg, G. G., Kochman, M. L., Canto, M. I., Goggins, M., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001835 · Cited by 24
Self-citationSerum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma
Yablecovitch, D., Ben‐Horin, S., Picard, O., Yavzori, M., Fudim, E., Nadler, M., Levy, I., Sakhnini, E., Lang, A., Engel, T., et al. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000473 · Cited by 21
Current Screening Strategies for Pancreatic Cancer
Vaněk, P., Urban, O., Zoundjiekpon, V., & Falt, P. (2022) · Biomedicines · doi:10.3390/biomedicines10092056 · Cited by 21
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
Peters, M. L. B., Tseng, J. F., & Miksad, R. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.006 · Cited by 21
Genetic Syndromes with Pancreatic Manifestations
Pittman, M. E., Brosens, L. A. A., & Wood, L. D. (2016) · Surgical pathology clinics · doi:10.1016/j.path.2016.05.012 · Cited by 21
Pancreatic cancer screening: Still a delusion?
Moutinho-Ribeiro, P., Coelho, R., Giovannini, M. F., & Macedo, G. (2017) · Pancreatology · doi:10.1016/j.pan.2017.07.001 · Cited by 21
Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.
McAllister, F. M., Montiel, M. F., Uberoi, G. S., Uberoi, A., Maitra, A., & Bhutani, M. S. (2017) · Europe PMC (PubMed Central) · Cited by 21
DePersia, A., Blazer, K. R., Stoll, J., Jones, M., Weipert, C. M., Nielsen, S. M., Kupfer, S. S., Weitzel, J. N., & Olopade, O. I. (2018) · Familial Cancer · doi:10.1007/s10689-018-0070-x · Cited by 22
Younan, G. J. (2020) · Surgical Clinics of North America · doi:10.1016/j.suc.2020.02.008 · Cited by 20
The German National Case Collection for Familial Pancreatic Cancer (FaPaCa)
Bartsch, D. K., Matthäi, E., Mintziras, I., Bauer, C. A., Figiel, J. H., Sina-Boemers, M., Gress, T. M., Langer, P., & Slater, E. P. (2021) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0004 · Cited by 21
A Review of Mucinous Cystic and Intraductal Neoplasms of the Pancreatobiliary Tract
Özcan, K., & Klimstra, D. S. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0399-ra · Cited by 20
Saba, H., & Goggins, M. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.006 · Cited by 20
Self-citationMustafa, M., Abbas, K., Alam, M., Habib, S., Zulfareen, Hasan, G. M., Islam, S., Shamsi, A., & Hassan, M. I. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1427802 · Cited by 25
Sato, Y., Kobayashi, T., Nishiumi, S., Okada, A., Fujita, T., Sanuki, T., Kobayashi, M., Asahara, M., Adachi, M., Sakai, A., et al. (2020) · Cancers · doi:10.3390/cancers12092625 · Cited by 20
Genetic Counseling and Surveillance Focused on Lynch Syndrome
Kim, J. Y., & Byeon, J. (2019) · Journal of the Anus Rectum and Colon · doi:10.23922/jarc.2019-002 · Cited by 19
Visser, I. J., Levink, I. J. M., Peppelenbosch, M. P., Fuhler, G. M., Bruno, M. J., & Cahen, D. L. (2022) · Pancreatology · doi:10.1016/j.pan.2022.06.260 · Cited by 21
Self-citationPancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
Badheeb, M. A., Abdelrahim, A., Esmail, A., Umoru, G., Abboud, K., Al-Najjar, E., Rasheed, G. O., Alkhulaifawi, M., Abudayyeh, A., & Abdelrahim, M. (2022) · Current Oncology · doi:10.3390/curroncol29110686 · Cited by 20
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence
Granata, V., Fusco, R., Setola, S. V., Galdiero, R., Maggialetti, N., Silvestro, L., Bellis, M. D., Girolamo, E. D., Grazzini, G., Chiti, G., et al. (2023) · Cancers · doi:10.3390/cancers15020351 · Cited by 19
Hamartomatous polyps: Diagnosis, surveillance, and management
Gorji, L., & Albrecht, P. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i8.1304 · Cited by 19
Síndromes de predisposición a cáncer gástrico y cáncer pancreático
Leoz, M. L., Sánchez, A., Carballal, S., Ruano, L., Ocaña, T., Pellisé, M., Castells, A., Balaguer, F., & Moreira, L. (2016) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2015.11.009 · Cited by 19
Das, K. K., & Early, D. S. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0149-8 · Cited by 19
Aspinwall, L. G., Stump, T. K., Taber, J. M., Drummond, D. M., Kohlmann, W. K., Champine, M., & Leachman, S. A. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/ibx011 · Cited by 19
New advances in CT imaging of pancreas diseases: a narrative review
Agostini, A., Borgheresi, A., Bruno, F., Natella, R., Floridi, C., Carotti, M., & Giovagnoni, A. (2020) · Gland Surgery · doi:10.21037/gs-20-551 · Cited by 18
Kurlinkus, B., Ger, M., Kaupinis, A., Jasiūnas, E., Valius, M., & Šileikis, A. (2021) · Life · doi:10.3390/life11060542 · Cited by 18
Pauley, K., Khan, A., Kohlmann, W. K., & Jeter, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837057 · Cited by 18
Menko, F. H., Monkhorst, K., Hogervorst, F. B. L., Rosenberg, E. H., Adank, M. A., Ruijs, M., Bleiker, E. M. A., Sonke, G. S., Russell, N. S., Oldenburg, H. S. A., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103642 · Cited by 18
Bureš, J., Kohoutová, D., Škrha, J., Bunganič, B., Ngo, O., Suchánek, Š., Škrha, P., & Zavoral, M. (2023) · Cancers · doi:10.3390/cancers15143669 · Cited by 19
Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers
Laitman, Y., Keinan‐Boker, L., Liphshitz, I., Weissglas‐Volkov, D., Philipsborn, S. L., Schayek, H., & Friedman, E. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3340-4 · Cited by 18
ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer
Tanaka, Y., Kumagi, T., Terao, T., Kuroda, T., Yokota, T., Azemoto, N., Imamura, Y., Uesugi, K., Kisaka, Y., Shibata, N., et al. (2020) · Internal Medicine · doi:10.2169/internalmedicine.3748-19 · Cited by 18
Heritable Gastrointestinal Cancer Syndromes
Stoffel, E. M. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.04.008 · Cited by 18
Diagnosis and staging of pancreatic ductal adenocarcinoma
Guillén-Ponce, C., Blázquez, J., González, I., de‐Madaria, E., Montáns, J., & Carrato, A. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1681-7 · Cited by 18
van Marcke, C., Vikkula, M., & Duhoux, F. P. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.01.017 · Cited by 18
Screening for Pancreatic Cancer
Wada, K., Takaori, K., & Traverso, L. W. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2015.05.010 · Cited by 17
Bar-Mashiah, A., Aronson, A., Naparst, M. S., DiMaio, C. J., & Lucas, A. L. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01308-w · Cited by 17
Ishii, Y., Serikawa, M., Tsuboi, T., Kawamura, R., Tsushima, K., Nakamura, S., Hirano, T., Fukiage, A., Mori, T., Ikemoto, J., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020238 · Cited by 17
Cost‐effectiveness of pancreas surveillance: The CDKN2A ‐p16‐ Leiden cohort
Ibrahim, I. S., Vasen, H. F. A., Wasser, M. N. J. M., Feshtali, S., Bonsing, B. A., Morreau, H., Inderson, A., de Vos tot Nederveen Cappel, W. H., & van den Hout, W. B. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12360 · Cited by 17
Pancreatic Cancer Diagnostics and Treatment – Current State
Krška, Z., Sváb, J., Hoskovec, D., & Ulrych, J. (2015) · Prague Medical Report · doi:10.14712/23362936.2015.65 · Cited by 17
Hwang, I. K., Kim, H., Lee, Y. S., Kim, J., Cho, J. Y., Yoon, Y., Han, H., & Hwang, J. (2015) · Cancer Science · doi:10.1111/cas.12744 · Cited by 17
Patient experiences living with pancreatic cancer risk
Underhill-Blazey, M. L., Berry, D. L., Dalton, E., Schienda, J., & Syngal, S. (2015) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-015-0034-1 · Cited by 18
Kelly, K. A., Hollingsworth, M. A., Brand, R. E., Liu, C. H., Singh, V. K., Srivastava, S., Wasan, A. D., Yadav, D. K., & Andersen, D. K. (2015) · Pancreas · doi:10.1097/mpa.0000000000000552 · Cited by 17
Viro-immune therapy: A new strategy for treatment of pancreatic cancer
Ibrahim, A. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.748 · Cited by 17
Early detection of sporadic pancreatic cancer: time for change
Fric, P., Šedo, A., Škrha, J., Bušek, P., Laclav, M., Škrha, P., & Zavoral, M. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000904 · Cited by 16
Smith, L. M., Mahoney, D. W., Bamlet, W. R., Yu, F., Liu, S., Goggins, M., Darabi, S., Majumder, S., Wang, Q.-L., Coté, G. A., et al. (2024) · Pancreatology · doi:10.1016/j.pan.2024.10.012 · Cited by 17
Self-citationClinical characteristics of second primary pancreatic cancer
Jo, J. H., Cho, I. R., Jung, J. H., Lee, H. S., Chung, M. J., Bang, S., Park, S. W., Chung, J. B., Song, S. Y., & Park, J. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179784 · Cited by 16
Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer
Kandel, P., & Wallace, M. B. (2018) · Cancers · doi:10.3390/cancers10020054 · Cited by 16
Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video)
Suenaga, M., Sadakari, Y., Almario, J. A., Borges, M. W., Lennon, A. M., Shin, E.-J., Canto, M. I., & Goggins, M. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.02.026 · Cited by 16
Self-citationde Juan, F. M., Reolid, M., Lapiedra, C. M., de Alcántara, F. M., Soto, M. C., Fons, A. C., & Machado, I. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i9.390 · Cited by 16
Long-term positive psychological outcomes in an Australian pancreatic cancer screening program
O'Neill, R. S., Meiser, B., Emmanuel, S., Williams, D. B., & Stoita, A. (2019) · Familial Cancer · doi:10.1007/s10689-019-00147-3 · Cited by 16
A brief overview of antitumoral actions of bruceine D
Sin, Z. W., Bhardwaj, V., Pandey, A. K., & Garg, M. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00013 · Cited by 15
Patel, N. M., Petrinic, T., Silva, M., Soonawalla, Z. F., Reddy, S., & Gordon-Weeks, A. N. (2020) · Cancers · doi:10.3390/cancers12092353 · Cited by 15
Smith, J. P., Cao, H., Edmondson, E. F., Dasa, S. S. K., & Stern, S. T. (2021) · Biomolecules · doi:10.3390/biom11121766 · Cited by 15
Paiella, S., Marinelli, V., Secchettin, E., Mazzi, M. A., Ferretto, F., Casolino, R., Bassi, C., & Salvia, R. (2020) · Psycho-Oncology · doi:10.1002/pon.5370 · Cited by 15
Self-citationClinical Applications of Melanoma Genetics
Gabree, M., Patel, D., & Rodgers, L. (2014) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0282-8 · Cited by 15
Rahimi, E. F., Batra, S., Thosani, N. C., Singh, H., & Guha, S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4170-x · Cited by 15
Nakamura, M., Miyasaka, Y., Sadakari, Y., Date, K., & Ohtsuka, T. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12012 · Cited by 14
Pandharipande, P. V., Jeon, A., Heberle, C. R., Dowling, E. C., Kong, C. Y., Chung, D. C., Brugge, W. R., & Hur, C. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.005 · Cited by 15
Turner, K. M., Wilson, G. C., Patel, S. H., & Ahmad, S. A. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14585-y · Cited by 14
Sakaue, T., Terabe, H., Takedatsu, H., & Kawaguchi, T. (2024) · Hepatology Research · doi:10.1111/hepr.14081 · Cited by 14
Hereditary gastric and pancreatic cancer predisposition syndromes
Leoz, M. L., Sánchez, A., Carballal, S., Ruano, L., Ocaña, T., Pellisé, M., Castells, A., Balaguer, F., & Moreira, L. (2016) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2016.06.010 · Cited by 14
The Management of Chronic Pancreatitis
Patel, V. A., & Willingham, F. F. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.08.012 · Cited by 14
Amin, S., & DiMaio, C. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-19677-0_2 · Cited by 14
Wada, K., Takaori, K., Traverso, L. W., Hruban, R. H., Furukawa, T., Brentnall, T. A., Hatori, T., Sano, K., Takada, T., Majima, Y., et al. (2013) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-013-0611-5 · Cited by 14
Self-citationNext generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
Connor, A. A., & Gallinger, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1324296 · Cited by 14
Lachter, J., Rosenberg, C., Hananya, T., Khamaysi, I. N., Klein, A., Yassin, K., & Half, E. (2018) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10353 · Cited by 14
Hereditary Breast and Ovarian Cancer Syndrome
Petráková, K., Palácová, M., Schneiderová, M., & Standara, M. (2016) · Klinicka onkologie · doi:10.14735/amko2016s14 · Cited by 13
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer
Paiella, S., Secchettin, E., Lionetto, G., Archibugi, L., Azzolina, D., Casciani, F., Simeone, D. M., Overbeek, K. A., Goggins, M., Farrell, J. J., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006094 · Cited by 13
Self-citationHuang, C., Hecht, E. M., Soloff, E. V., Tiwari, H. A., Bhosale, P., Dasayam, A., Galgano, S. J., Kambadakone, A., Kulkarni, N. M., Le, O., et al. (2024) · American Journal of Roentgenology · doi:10.2214/ajr.24.31151 · Cited by 13
The interplay between microRNAs and Nrf2 signaling in human cancers
Panahizadeh, R., Vatankhah, M. A., Safari, A., Danesh, H., Nazmi, N., Gholizadeh, P., Soozangar, N., & Jeddi, F. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03430-1 · Cited by 16
Chiaro, M. D., Mucelli, R. P., Blomberg, J., Segersvärd, R., & Verbeke, C. S. (2013) · Familial Cancer · doi:10.1007/s10689-013-9696-x · Cited by 13
Screening of Patients at Risk for Familial Pancreatic Cancer
Torphy, R. J., & Schulick, R. D. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.09.003 · Cited by 13
Self-citationFranke, F. S., Matthäi, E., Slater, E. P., Schicker, C., Kruse, J., & Bartsch, D. K. (2018) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-018-0100-6 · Cited by 13
Pathology of intraductal papillary mucinous neoplasms
Assarzadegan, N., Thompson, E. D., Salimian, K. J., Gaida, M. M., Brosens, L. A. A., Wood, L. D., Ali, S. Z., & Hruban, R. H. (2021) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02201-0 · Cited by 15
Self-citationCombinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer
Slater, E. P., Wilke, L. M., Böhm, L. B., Strauch, K., Lutz, M., Krasser‐Gercke, N., Matthäi, E., Hemminki, K., Försti, A., Schlesner, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070631 · Cited by 14
Hijioka, S., Morizane, C., Takaori, K., & Okusaka, T. (2022) · Pancreatology · doi:10.1016/j.pan.2022.04.006 · Cited by 13
Korenevskiy, N. A., Belozerov, V. A., Al-Kasasbeh, R. T., Al-Smadi, M. M., Krutskikh, V. V., Shalimova, E. V., Al-Jundi, M., Rodionova, S. N., Filist, S., Shaqadan, A. A., et al. (2023) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2023049762 · Cited by 13
Management of Patients with Hereditary Colorectal Cancer Syndromes
Brandão, C., & Lage, J. (2015) · GE Portuguese Journal of Gastroenterology · doi:10.1016/j.jpge.2015.06.003 · Cited by 13
de Mestier, L., Müller, M., Cros, J. F., Vullierme, M., Vernerey, D., Maire, F., Dokmak, S., Rebours, V., Sauvanet, A., Lévy, P., et al. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640618824910 · Cited by 14
Pilot study of rapid MR pancreas screening for patients with BRCA mutation
Corrias, G., Raeside, M. C., Agostini, A., Castellanos, S. H., Aramburu‐Nunez, D., Paudyal, R., Shukla‐Dave, A., Smelianskaia, O., Capanu, M., Zheng, J., et al. (2019) · European Radiology · doi:10.1007/s00330-018-5975-0 · Cited by 13
Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography
González-Gómez, R., Pazo-Cid, R., Sarría, L., Morcillo, M. Á., & Schuhmacher, A. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061151 · Cited by 14
Kurita, A., Mori, Y., Someya, Y., Kubo, S., Azuma, S., Iwano, K., Ikeda, S., Okumura, R., & Yazumi, S. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03199-1 · Cited by 13
Hand, F., & Conlon, K. C. (2019) · Surgery (Oxford) · doi:10.1016/j.mpsur.2019.03.005 · Cited by 13
Bogdanski, A. M., Acedo, P., Wallace, M. B., van Leerdam, M. E., & Klatte, D. C. F. (2025) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2025.101974 · Cited by 12
Moutinho-Ribeiro, P., Batista, I. A., Quintas, S. T., Adem, B., Silva, M., Morais, R., Peixoto, A., Coelho, R., Costa‐Moreira, P., Medas, R., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i31.4310 · Cited by 12
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma
Firpo, M. A., Boucher, K. M., Bleicher, J. M., Khanderao, G. D., Rosati, A., Poruk, K. E., Kamal, S., Marzullo, L., Marco, M. D., Falco, A., et al. (2023) · JCO Clinical Cancer Informatics · doi:10.1200/cci.22.00160 · Cited by 12
Shou, S., Li, Y., Chen, J., Zhang, X., Zhang, C., Jiang, X., Liu, F., Li, Y., Zhang, X., Geer, E., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00768-6 · Cited by 11
The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
Tan, Z., Meng, Y., Wu, Y., Zhen, J., He, H., Pu, Y., Zhang, J., & Dong, W. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00820-0 · Cited by 12
Liu, W. C., Rao, L., Qiao, Z.-G., Wang, G., Li, B., & Shen, G. (2025) · BMC Cancer · doi:10.1186/s12885-025-14110-2 · Cited by 14
Genetics of pancreatic cancer and implications for therapy
Bhosale, P., Cox, V. L., Faria, S. C., Javadi, S., Viswanathan, C., Koay, E. J., & Tamm, E. P. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1394-y · Cited by 12
Matsubayashi, H., Kiyozumi, Y., Ishiwatari, H., Uesaka, K., Kikuyama, M., & Ono, H. (2019) · Diagnostics · doi:10.3390/diagnostics9040169 · Cited by 12
Ullah, A. Z. M. D., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09014-w · Cited by 11
Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms
Honda, K. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210198 · Cited by 12
Boland, C. R., Idos, G., Durno, C. A., Giardiello, F. M., Anderson, J. C., Burke, C. A., Dominitz, J. A., Gross, S. A., Gupta, S. N., Jacobson, B. C., et al. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2022.02.044 · Cited by 12
Genetics of Pancreatic Neoplasms and Role of Screening
Katabathina, V. S., Rikhtehgar, O. Y., Dasyam, A. K., Manickam, R., & Prasad, S. R. (2018) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2018.03.005 · Cited by 12
Farrell, J. (2018) · Endoscopic Ultrasound · doi:10.4103/eus.eus_49_18 · Cited by 12
Vasen, H. F. A., Boekestijn, B., Ibrahim, I. S., Inderson, A., Bonsing, B. A., de Vos tot Nederveen Cappel, W. H., Feshtali, S., & Wasser, M. N. (2019) · HPB · doi:10.1016/j.hpb.2019.02.013 · Cited by 12
Screening guidelines and recommendations for patients at high risk of developing endocrine cancers
Geurts, J. L., Strong, E. A., Wang, T. S., Evans, D. B., & Clarke, C. N. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.25869 · Cited by 12
Identifying key factors for the effectiveness of pancreatic cancer screening: A model‐based analysis
Koopmann, B. D. M., Harinck, F., Kroep, S., Konings, I. C. A. W., Naber, S. K., Lansdorp‐Vogelaar, I., Fockens, P., van Hooft, J. E., Cahen, D. L., van Ballegooijen, M., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33540 · Cited by 12
Self-citationThe benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants
Laish, I., Schechter, M., Dancour, A., Lieberman, S., Levi, Z., Goldberg, Y., Kedar, I., Hasnis, E., Half, E., Levi, G. R., et al. (2023) · Cancer · doi:10.1002/cncr.35052 · Cited by 12
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer
Bogdanski, A. M., van Hooft, J. E., Boekestijn, B., Bonsing, B. A., Wasser, M. N. J. M., Klatte, D. C. F., & van Leerdam, M. E. (2024) · Familial Cancer · doi:10.1007/s10689-024-00368-1 · Cited by 12
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
